Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

9.140 -0.090 (-0.98%)
Streaming Delayed Price Updated: 10:51 AM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Should You Buy the Dip on Ginkgo Bioworks Stock? ↗
Its vision is ambitious, but can it actually be made to work? 
Via The Motley Fool
News headline image
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk ↗
You don't need to buy her picks, but it's worth understanding them. 
Via The Motley Fool
News headline image
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF ↗
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings. 
Via Benzinga
Topics ETFs
News headline image
3 Things You Need to Know if You Buy Ginkgo Bioworks Today ↗
It needs to work within the constraints imposed by these three issues. 
Via The Motley Fool
News headline image
Down 72%. Is Ginkgo Bioworks a Buy on the Dip? ↗
The number of cell engineering partnerships Ginkgo Bioworks has is way up, but the same can't be said about its stock price. 
Via The Motley Fool
News headline image
How Is The Market Feeling About Ginkgo Bioworks Holdings? ↗
 
Via Benzinga
News headline image
Is Ginkgo Bioworks Holdings Stock a Buy? ↗
Can this struggling stock turn things around? 
Via The Motley Fool
News headline image
Ginkgo Bioworks: Buy, Sell, or Hold? ↗
This company has a long way to go before investors will see rewards. 
Via The Motley Fool
News headline image
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst ↗
Ginkgo Bioworks has become a penny stock -- and that's the least of its problems, 
Via The Motley Fool
News headline image
Investment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!' ↗
Ram Ahluwalia of Lumida Wealth pointed to Ark's flagship ETF trading over 70% below its all-time high amid the S&P 500's recent record highs. 
Via Benzinga
Topics ETFs Stocks
News headline image
4 Small-Cap Value Stocks That Could Go Parabolic ↗
These four small-cap stocks scan as deeply undervalued right now. 
Via The Motley Fool
News headline image
What's the Difference Between Biotech Stocks and TechBio Stocks? ↗
A few enterprising businesses are marketing themselves differently. 
Via The Motley Fool
News headline image
TeraWulf Posts Weak Results, Joins StoneCo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest ↗
 
Via Benzinga
News headline image
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning! 
Via InvestorPlace
News headline image
Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
DNA Stock Earnings: Ginkgo Bioworks Holdings Meets EPS, Misses Revenue for Q1 2024 ↗
DNA stock results show that Ginkgo Bioworks Holdings met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change' ↗
Ginkgo Bioworks reported quarterly sales of $38 million which missed the analyst consensus estimate of $46.044 million by 17.47% and is a 52.91% decrease in sales year-over-year. The company said the... 
Via Benzinga
News headline image
3 Meme Stocks to Sell in May Before They Crash & Burn ↗
Traders have gravitated to meme stocks over the past year. But it's time to sell these three before the party ends. 
Via InvestorPlace
News headline image
Want $10,000? Invest $1,000 in These 3 Penny Stocks Now ↗
Let's dive into these three high-potential penny stocks to discover whether or not they offer genuine investment opportunities. 
Via InvestorPlace
News headline image
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today? ↗
Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering. 
Via InvestorPlace
News headline image
Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock? ↗
DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze. 
Via InvestorPlace
News headline image
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks. ↗
The collaboration could help solve challenges for both businesses. 
Via The Motley Fool
News headline image
What's Going On With Ginkgo Bioworks Stock? ↗
Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk A/S on Wednesday under a framework agreement that initially is contemplated to run over five years.Ginkgo said the... 
Via Benzinga
News headline image
Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗
These stocks, a bargain today, are players to hold on to for the long term. 
Via The Motley Fool
News headline image
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation ↗
They might not be profitable yet, but they're swinging for the fences. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now? ↗
These stocks could rocket higher, but they also present significant risks. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.